Standard BioTools(LAB.US) 10% Shareholder Buys US$260K in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 100K shares of common stock on May 23, 2024 at an average price of $2.6 for a total value of $260K. This transac
Express News | Standard BioTools Purchases The Carterra LSA-XT System; No Financial Terms Disclosed
Express News | Standard BioTools Purchases the Carterra® Lsa-Xt System to Accelerate Data Delivery and Provide Greater Validation to Somascan Customers
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
Standard BioTools(LAB.US) 10% Shareholder Buys US$1.54 Million in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 600K shares of common stock on May 20, 21, 22, 2024 at an average price of $2.5697 for a total value of $1.54 mi
Standard BioTools to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ("Standard BioTools") (NASDAQ:LAB) today announced that its management team will participate in the following investor conferences in
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed above the $40,000 mark on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inter
Express News | Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Standard BioTools(LAB.US) 10% Shareholder Buys US$3.46 Million in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 1.35 million shares of common stock on May 15, 16, 17, 2024 at an average price of $2.5557 for a total value of
Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript
Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript
Standard BioTools | 10-Q: Quarterly report
Express News | Standard BioTools Reaffirms Guidance
Standard BioTools: Strategic Insights and Regulatory Updates
Standard BioTools Q1 2024 GAAP EPS $(0.27) Misses $(0.12) Estimate, Sales $45.540M Miss $46.006M Estimate
Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.12) by 125 percent. This is a 28.57 percent decrease over losses of $(0
Express News | Standard BioTools Inc FY2024 Rev View $201.0 Mln -- Lseg Ibes Data
Express News | Standard BioTools Inc: Qtrly Shr Loss $0.27
Express News | Standard BioTools Inc: For Fiscal Year 2024, Co Reaffirmed Full Year Revenue Guidance
Express News | Standard BioTools Inc: On Track to Cash Flow Positive in Full-Year 2026
Standard BioTools Backs 2024 Rev $200M-$205M >LAB
Standard BioTools Backs 2024 Rev $200M-$205M >LAB
Standard BioTools 1Q Loss/Shr 27c >LAB
Standard BioTools 1Q Loss/Shr 27c >LAB
No Data